What We're Reading: Page
Industry reads hand-picked by our editors
Jan 24, 2019
-
Financial Times
UK biotech doubles investment but offers few IPOs
-
The Guardian
Pharma firms to be incentivised to develop new superbug drugs
-
Nature
Gene therapies in ophthalmic disease
Jan 23, 2019
Jan 22, 2019
-
The Wall Street Journal
One Family’s Struggle to Get Their Daughter Lifesaving Medication
-
Evaluate
Gene therapy: how much will it cost patients?
-
The New York Times
Coming Soon to a Police Station Near You: The DNA 'Magic Box'
-
Axios
Drug makers still raising prices, but seeking fewer hikes
Jan 18, 2019
Jan 17, 2019
Jan 16, 2019
Jan 15, 2019
-
Vantage
Why Novo Nordisk should buy Amarin
-
BioCentury
Amid Onpattro launch, Alnylam raises $387.5M
-
The Wall Street Journal
In Fast-Aging Japan, Elder Care Is a High-Tech Pursuit
-
The Wall Street Journal
Walmart Expected to Leave CVS Caremark Pharmacy Networks Amid Dispute
Previous
